STOCKHOLDERS’ DEFICIT |
3 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ DEFICIT | 11. STOCKHOLDERS’ DEFICIT
Authorized share
The Company has 400,000,000 shares of Series A Preferred Stock authorized with a par value of $0.00001 per share.
The Company has 27,600,000,000 shares of Common Stock authorized with a par value of $0.00001 per share.
As of June 30, 2026 and March 31, 2026, the Company had 27,600,000,000 and 27,600,000,000 shares of common stock authorized, respectively.
Preferred stock
As of June 30, 2026 and March 31, 2026, the Company had no shares of Series A Preferred Stock issued and outstanding, respectively.
Common stock
As of June 30, 2026 and March 31, 2026, the Company had 12,715,111 and 12,715,111 shares of its common stock issued and outstanding, respectively.
Shares to be issued
On August 3, 2026, the Company received the Notice and agreed to issue Mr. Huang Hsiang-An 29,304 shares of its common stock at the price of $3.50 per share, equal to $102,564 to settle convertible debts payable on August 11, 2026.
As of June 30, 2026 and March 31, 2026, the Company had 29,304 and 0 shares of common stock to be issued, respectively.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|